Product logins

Find logins to all Clarivate products below.


Orthopedic Surgical Robotic Devices – Market Insights – Global

Rising demand for robot-assisted procedures for both large-joint replacement and spinal fusion market, innovations like real-time 3-D modelling, updated hardware and AI driven software will help fuel growth in the orthopedic surgical robotic devices market. This demand is influenced by several factors, including the shift towards ASCs, positive clinical trial outcomes, expansion into new medical indications, approval of new robotic systems, and increased regional adoption.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for orthopedic surgical robotic devices in the US, Europe, Asia Pacific, and the Latin American region from 2019 through 2034.

The shift toward performing associated procedures in ASCs will have an impact on the orthopedic surgical robotic market.

How is the shift of procedures to the ASC setting shaping innovation?

How is reimbursement affecting sites of service for implant procedures?

How does this migration to the outpatient setting affect procedure ASPs?

Which products are being developed to enable shorter surgery and recovery times in outpatient settings?

The US orthopedic surgical robotic device market will grow strongly.

What factors are driving such strong market expansion?

How does growth vary in different market segments?

What limiters exist that could impede revenue potential?

Expansion into new indications is increasing the total treatable population and driving growth in the orthopedic surgical robotic market.

What is the penetration of robotics into the various orthopedic procedures?

Which robotic-assisted procedures will see the highest growth?

How does the penetration and growth of robotic-assisted procedures differ between geographical regions?

Ongoing Innovation by manufacturers is driving adoption.

What are the recent innovations in robotics from major competitors in the large-joint reconstructive implant space?

Who are the new entrants into the robot-assisted market?

How are companies changing their product mix in response to trends surrounding robotic assistance, navigation technologies, and personalized implants?

What new software and analytic capabilities are manufacturers adding to their service offerings?

Competition in this market is becoming more intense as new robotic systems receive regulatory approval.

Which competitors have a strong presence, and which of them have emerged stronger than the others?

Which players have benefited from early approvals and which companies are likely new entrants into this market going forward?

Which product segments should competitors focus on for growth opportunities?

How are companies expanding their offerings through product innovation, mergers, acquisitions, and/or partnerships to capture a larger share in the market?

Table of contents


Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Pain Management Devices – Market Insights – United States
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…